Tech Company Financing Transactions

Vedana Therapeutics Funding Round

Vedana Therapeutics, operating out of Seattle, raised $46 million in funding from Canaan Partners, Westlake Village BioPartners and Alexandria Venture Investments.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

Undisclosed
Seattle, WA Undisclosed
USA

Phone

Undisclosed

Website

www.vedanatx.com

Email Address

[email protected]

Overview

Vedana Therapeutics is developing innovative medicines to help patients achieve migraine freedom. Vedana is developing a portfolio of long-acting subcutaneously dosed monoclonal antibodies targeting PACAP and other clinically emerging pathways to redefine the standard of care for migraine patients.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Anurag Agarwal

        

Chief Marketing Officer

Ernesto Aycardi

        

Chief Scientific Officer

Leon Garcia

        

VP - Bus. Development

Augustine Bourne

        

Browse more venture capital transactions:

Prev: 6/22/2026: Isometric venture capital transaction
Next: 6/22/2026: Upscale AI venture capital transaction

Share this article

About Our VC Transactions Data

We do our best to report on tech company VC transactions. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary